Clifford Bechtold
Compliance Officer presso BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profilo
Clifford Bechtold è un direttore operativo della Biohaven Pharmaceutical Holding Co. Ltd. Il sig. Bechtold è stato precedentemente impiegato come vicepresidente delle operazioni strategiche di Adnexus e come direttore del personale di Bristol Myers Squibb Co. Si è laureato alla South Dakota State University e si è laureato alla Creighton University School of Medicine.
Posizioni attive di Clifford Bechtold
| Società | Posizione | Inizio |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - |
| BIOHAVEN LTD. | Compliance Officer | - |
Precedenti posizioni note di Clifford Bechtold
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2013 |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/10/2011 |
Formazione di Clifford Bechtold
| South Dakota State University | Undergraduate Degree |
| The Creighton University School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Clifford Bechtold
